Document is current
Any future updates will be listed below
-
Authors
Wilson, Christopher https://orcid.org/0000-0002-8012-2440
Chen, Peter J.
Miao, Zhuang
Liu, David R. https://orcid.org/0000-0002-9943-7557
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (RM1 HG009490)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (U01 AI142756)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35 GM118062)
Howard Hughes Medical Institute (Liu Investigatorship)
- License Information
-
More Information
Article History
Received: 5 December 2019
Accepted: 20 May 2020
First Online: 29 June 2020
Competing interests
: D.R.L. is a consultant and co-founder of Beam Therapeutics, Prime Medicine, Editas Medicine and Pairwise Plants, companies that use genome editing. D.R.L., P.J.C. and C.W. have filed patent applications on aspects of this work.
